Organoids take the prize
Ardigen, a leading provider of AI-driven solutions for drug discovery and development, is pleased to announce its partnership with Databricks, the Data and AI company.
This collaboration brings forth the Clinical Data Lakehouse—an innovative, scalable, and compliant data management solution built on the Databricks Lakehouse platform—designed to enhance clinical trial operations.
Pharmaceutical and biotechnology companies face growing challenges in managing vast and complex clinical datasets. The Clinical Data Lakehouse addresses these challenges by providing real-time analytics, seamless data integration, and AI-ready infrastructure to empower clinical operations teams, medical directors, biomarker experts, and senior executives with deeper insights and improved efficiency.
Key benefits of the Clinical Data Lakehouse:
- Unified & Scalable Data Management: Integrates clinical and biomarker data across multiple trials into a single, scalable platform.
- Regulatory Compliance & Security: Ensures adherence to industry regulations while maintaining full data control across AWS, Azure, and GCP
AI-Driven Insights: Prepares data for advanced AI analytics, enabling rapid deployment of dashboards and predictive models.
“Our partnership with Databricks allows us to deliver a robust, AI-ready solution tailored to the life sciences industry’s need for better, data-driven decision-making in clinical trials. The Databricks Lakehouse platform empowers us to offer scalable, compliant solutions that drive AI-powered clinical insights,” said Łukasz Nowak, COO at Ardigen.
By leveraging the Databricks Lakehouse architecture, Ardigen is setting a new standard in clinical trial data management—helping life sciences companies streamline operations, accelerate insights, and unlock the full potential of their data.
For more information, visit https://ardigen.com.
